D. Shane O’Mahony

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19”.

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Cell(2020)10.1016/j.cell.2020.10.037

N/A

9.7DataRank · unranked

643 citations

Daniel Chen, Dan Yuan, Christopher Lausted, Jongchan Choi, Chengzhen L. Dai +50 more

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00147-9

N/A

0.869DataRank · unranked

19 citations

Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew Phillips, Lindsay Leither +95 more

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.27.224063

N/A

0DataRank · unranked

17 citations

Daniel Chen, Christopher Lausted, Dan Yuan, Jongchan Choi, Cheng Dai +44 more